Related Experiment Video
Updated: Jun 18, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Residue-Level Affinity Decomposition via Quantum Electron Density: A Multivariable Framework Applied to HIV-1
Jorge Gutiérrez-Flores1, Gerardo Padilla-Bernal1, César Sánchez-Juárez1
1Departamento de Química, División de Ciencias Básicas e Ingeniería, Universidad Autónoma Metropolitana Iztapalapa, San Rafael Atlixco 186, Col. Vicentina, C.P., 09340 Iztapalapa CDMX, México.
This study introduces a quantum-informed framework to analyze protein-ligand binding, revealing that specific interactions, not just quantity, dictate affinity. This method aids in designing better drug inhibitors.
Area of Science:
- Computational Chemistry
- Structural Biology
- Drug Design
Background:
- Protein-ligand binding is crucial for drug development but challenging to predict.
- Understanding molecular interactions is key for rational drug design.
Purpose of the Study:
- To develop a quantum-informed, residue-level framework for protein-ligand affinity decomposition.
- To analyze noncovalent interactions between HIV-1 protease and inhibitors.
Main Methods:
- Integrated molecular dynamics, DFT, QTAIM analysis, and multivariable modeling.
- Quantified noncovalent interactions and analyzed residue-specific contributions.
- Used Hessian-based descriptors and NCI index for physical interpretation.
Main Results:
- Affinity is governed by the nature of individual contacts, not their overall number or density.
- Models distinguished stabilizing and destabilizing residue contributions, including water's influence.
- Quantum descriptors showed predictive value compared to MM-PBSA.
Conclusions:
- Developed a transferable, quantum-topological framework for mechanistic protein-ligand affinity analysis.
- The approach is applicable to diverse chemical scaffolds, aiding inhibitor optimization.
- Provides a generalizable strategy for structure-guided drug design.
More Related Videos
19:23Use of Recombinant Fusion Proteins in a Fluorescent Protease Assay Platform and Their In-gel Renaturation
Published on: January 16, 2019
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025